The Swiss medtech startup’s sweat-based molecular tracking aims to prevent preterm births and empower doctors with continuous, personalised data.
MoleSense has raised €156k across 1 funding round from 1 investor, most recently a round in Oct 2025. Based in Lausanne, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-10-28 | Other | €156k |
| Venture Kick |
| View deal → |
